Protedyne to Install BioCube System at Correlagen Diagnostics Laboratory
"We're delighted to have been chosen by Correlagen as their automation partner. Correlagen is just the type of company that will benefit greatly from Protedyne's total solution approach to automation," said Catherine Williams, Vice President of Sales and Marketing at Protedyne. "The BioCube(TM) System is a perfect complement to the advanced work being done at Correlagen."
"The integration of a BioCube System with Correlagen's proprietary software will enable Correlagen to sequence human genes for clinical diagnostic purposes at very low cost," said David M. Margulies, M.D., Correlagen's Chief Executive Office. "We are impressed with the elegant engineering that Protedyne brings to the processes of laboratory automation and plan to launch our next line of sequencing assays on a BioCube System this fall," added Margulies.
Other news from the department business & finance
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.